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Abstract 
We present a case of fatal intoxication by the application of a transdermal fentanyl patch upon 
a superficial bleeding abrasion of a 2-year-old girl. The grandmother discovered the body of 
the child in bed at approximately 7 a.m. External examination revealed a properly developed, 
nourished and hydrated child, with some vomit in the nostrils and inside the mouth. There was 
no evidence of trauma besides small contusions and abrasions on knees, with a patch placed 
over the largest abrasion. Closer inspection revealed that this was transdermal fentanyl patch. 
Internal examination and microscopic analysis revealed regurgitation of stomach content, 
cerebral and pulmonary edema and liver congestion. Toxicology analysis revealed trace levels 
of fentanyl in the blood just above the limit of detection (2 ng/mL), while concentrations in 
the urine, liver and kidney were approximately 102, 28 and 10 ng/mL, respectively.  
Investigation discovered that the child injured her knee while playing the evening before. The 
grandmother applied the patch to cover the injury, unaware that she had used a fentanyl 
transdermal patch instead of simple band-aid.  
Although fatal intoxications are uncommon among young children in high-income countries, 
it is of major interest to raise awareness of such events especially since a great majority of 
these are preventable. The presented case points at the need for more thorough education of 
users and more strict rules in prescribing and handling of this potent medicine. As well, we 
find this case to be a useful contribution to the evaluation of postmortem fentanyl 
concentrations in fatal intoxication in a small child. 
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Introduction 
Unnatural causes of death in children younger than 4 years of age accounted for 8.81% of all 
causes of death in developed countries in year 2008, according to the World Health 
Organization [1]. Road traffic accidents and drowning were most common while poisoning 
was a rare event represented with 2% of all unnatural deaths and 0.15% of all deaths in this 
age group [1]. 
Substances usually identified as the causative agent in fatal poisoning in children less than 5 
years of age are divided into pharmaceutical and non-pharmaceutical agents, in similar 
proportion of incidence [2]. The most frequent pharmaceutical agents in fatal poisoning are 
opioid analgesics, cardiovascular drugs and paracetamol [3]. Unlike fatal poisoning, nonfatal 
poisoning is rather common among children. According to the Annual Reports of the 
American Association of Poison Control Centers' for years 2010 and 2011, over 1 million of 
poison exposures among children younger than six years of age are reported in United States 
every year [2, 4]. A great majority of poisonings in this age group are unintentional and occur 
at home (90%) [2, 4]. 
Fentanyl is a very potent synthetic μ-opioid receptor agonist widely used in anesthesia or as 
an analgesic for intense chronic pain treatment. It is available for oral transmucosal and 
parenteral administration, as well as for transdermal use. In chronic pain treatment, fentanyl is 
commonly used in the form of transdermal patches which are available in doses of 12, 25, 50, 
75 and 100 μg/h. The emergence of effects of fentanyl (analgesia, hypoventilation, sedation, 
coma, respiratory and central nervous system depression and death) depends upon the dose, 
patients’ tolerance of opioids and serum fentanyl concentrations.  
Adverse reactions in the form of life threatening conditions due to improper use of the 
fentanyl transdermal patch in children have been reported [5-8], as well as fatalities [9-11]. 
Herein we present a case of fatal poisoning caused by application of transdermal fentanyl 
patch on bleeding wound of a 2-year old child. 
 
Case history 
A 2-year-old girl was found dead at approximately 7 a.m. by her grandmother who had put 
her to bed evening before. Upon arrival to the scene, the emergency medical team was only 
able to confirm death. During the morning, the attending coroner examined the body. The 
body was sent to postmortem examination which was performed the following day. The 
external examination revealed a properly developed, well nourished (91 cm long, weighting 
12 kg) and hydrated female child. A trace of dark vomit was visible in the nostrils and inside 
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the mouth. There was no evidence of external trauma except for the small contusions and 
abrasions on both knees and lower legs. A patch had been placed over the biggest abrasion 
(2x2 cm) located on the front side of the right knee. A closer look revealed that this wasn’t a 
simple band-aid commonly used to treat superficial injuries. It was a rectangular, semi-
translucent patch with the light imprint "Durogesic 25 μg/h". Internal examination and 
following microscopic analysis of sampled tissues revealed stomach content inside the 
esophagus, trachea and bronchi, cerebral and pulmonary edema, and liver congestion. 
Samples of body fluids (femoral blood, urine and gastric content) and tissues (liver and 
kidney) were taken for subsequent toxicology analysis.  
Toxicology analysis revealed the presence of fentanyl in the femoral blood, urine, liver and 
kidney samples, while the gastric content showed no traces of fentanyl (Table 1 and Figure 1). 
 
 
Sample Fentanyl 
(ng/mL or ng/g) 
Alcohol 
(g/kg) 
Carboxyhemoglobin 
(%) 
Femoral blood  Trace   (LOD=2) not detected not detected 
Urine  102 not detected  
Liver  28   
Kidney  10   
Gastric content  not detected   
 
Table 1: Results of toxicology analyses of fluids and tissues – the concentrations of fentanyl 
are approximate (pharmaceutical solution was used due to the lack of an internal standard) 
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Figure 1: Total ion chromatogram of the urine sample and mass spectrum of the fentanyl 
 
 
The victims’ family was invited to bring the patches they used to treat the abrasion on the 
knee and what they brought were two unused Durogesic 25 μg/h transdermal patches.  
The following investigation revealed that the child came with the parents to visit the 
grandmother. During the afternoon, while playing in the courtyard, around 6:30 p.m., the 
child fell to the ground and injured her right knee. The abrasion bled fairly well so the 
grandmother placed the patch directly on the wound to stop the bleeding. During the next 
couple of hours the child continued to play without any apparent mood change. At 
approximately 9 p.m. the child stated that she was sleepy and, only few minutes after, fell 
asleep in her grandmothers’ lap. This time of evening was the child’s usual bed time so the 
parents decided to leave her at her grandmothers’ place. During the night, at approximately 1 
a.m., the grandmother heard the child breathing harder, wheezing and snoring, so she placed 
her on her side which, allegedly, helped child breathe easier. At approximately 7 a.m., the 
grandmother found the child lying in the bed at the same position, with her body cold and 
initially rigid.    
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Two additional fentanyl transdermal patches were found by parents at grandmothers’ place. 
The origin of the patches remained unrevealed. None of the family members had a 
prescription for the usage of transdermal fentanyl patch and the grandmother could not recall 
(or decided not to tell) how she came to possess the transdermal fentanyl patches. Records at 
the grandmothers’ general practitioner were devoid of any medical condition that could be 
connected with the need for serious analgesic treatment.  
Once the police investigation concluded, the authorities charged the grandmother with death 
by negligence. 
 
Materials and methods 
Biological samples collected during the autopsy were submitted to toxicology analysis. 
 
Chemicals and standards 
A 10 mL ampule of Fentanyl Torrex 50 µg/mL solution for injection (Chiesi Pharmaceuticals 
GmbH, Vienna, Austria) was used as the calibration standard.  Methanol, chloroform, ethyl 
acetate, sodium hydroxide and acetic acid were pro analysis grade (Kemika Zagreb, Croatia). 
L-Cysteine BioUltra was purchased from Sigma-Aldrich (Steinheim, Germany). Polymeric 
adsorbent Supelco-Amberlite® XAD®-2 was purchased from Sigma-Aldrich (Bellefonte, PA, 
USA). Supelco Reusable sample cleanup columns, Champagne design (160 mm long, 36 mm 
I.D., 6 mm stem I.D.) was purchased from Sigma-Aldrich (Taufkirchen, Germany). 
 
Sample preparation 
Collected biological samples were prepared using the following method: 100 mg of L-
Cysteine, 3 mL of water and 1 mL of concentrated HCl were added to biological samples (5 
mL or 5 g tissue homogenate); samples were hydrolyzed at 90°C for 30 min, cooled to room 
temperature, adjusted to pH 8-9 with 0.1M NaOH and filtrated before extraction. Glass SPE 
column filed with Amberlite XAD-2 resin was activated with 25 mL of methanol and 10 ml 
of 0.01M NaOH. Prepared samples were drawn slowly through the column. The column was 
washed with 25 mL of water and eluted with 25 mL of chloroform:ethyl acetate (2:3, v/v). 
Liquid-liquid extraction of gastric content (1 mL) was performed with 5 mL of chloroform.     
Quantification in urine, kidney and liver was performed by means of standard addition of 50 
and 100 ng/mL or ng/g of fentanyl. 
The concentrations of alcohol in blood and urine samples were determined using head space 
gas chromatography.  
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The carboxyhemoglobin concentration was determined by Heilmeyer method using VIS-
spectrophotometer. 
 
Instrumentation 
The gas chromatography – mass spectrometry (GC–MS) analyses were performed using 
Agilent 5973N Mass Selective Detector, 6890 Gas Chromatograph and 7683 Automatic 
Liquid Sampler equipped with an Elite–5 capillary column (25 m × 0.32 mm ID, 520 nm film 
thicknesses). The analyses were performed using total ion monitoring mode. Sample volume 
of 1 µL was injected in splitless mode. The temperatures at the injector, MS interface, 
electron impact source and mass filter were set at 250°C, 280°C, 230°C and 150°C 
respectively. The initial set point of a carrier (helium) was 0.5 mL/min. The initial oven 
temperature of 90°C was held for 3 min, increased to 270°C at a rate of 15°C/min, then 
increased to 300°C at a rate of 10°C/min and held for 17 min.  
The fentanyl was identified according to its retention time and three characteristic ions (m/z 
245, 146, 189). The most abundant ion was used for quantification and the second and third 
ions were used for the confirmation. 
 
Method validation 
The selectivity of the method was tested on ten post-mortem blood samples and there were no 
signals interfering with the signal of the fentanyl. 
Limit of detection (LOD) was estimated by spiking blank blood samples with calibration 
standards in the range from 1 to 5 ng/mL with step of 1 ng/mL. Each level was repeated five 
times. Based on a signal-to-noise (S/N) ratio of 3, a LOD of 2 ng/mL was achieved. 
Inter-day precision and accuracy were determined at two different concentrations in five 
consecutive days. The blood samples were spiked with fentanyl at low (5 ng/mL) and high 
(100 ng/mL) calibration levels. Accuracy is expressed as a percent deviation from the 
accepted reference value and was within ±5.0%. Precision is expressed as relative standard 
deviation (RSD, %) and was within 12.3%.  
 
Results 
Results of the toxicology analysis of fluids and tissues are shown in Table 1. Qualitative 
analysis confirmed the presence of fentanyl in the blood, urine, liver and kidney. The fentanyl 
was not detected in the gastric content. The total ion chromatogram of the urine sample and 
mass spectrum of the fentanyl are shown in Figure 1.  
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Due to the lack of the calibrated reference standard, as well as the lack of time for ordering 
the standard, we obtained the ampule of fentanyl solution for parenteral use which we used as 
a calibration standard. Concentration of the active substance in pharmaceutical products is 
allowed to vary +/- 5 % of the declared concentration. Therefore, use of fentanyl solution as 
calibration standard leads to additional uncertainty. Since no internal standard and no 
calibrated reference standard were used, the precision level was lower and obtained 
concentrations are approximate but still acceptable for practical purposes. 
The concentration of fentanyl in the femoral blood was barely detectible and there was no 
remaining blood sample for repetition by more sensitive method extraction procedure with 
internal standard. Therefore, we determined the limit of detection (LOD), precision and 
accuracy of the applied method. The internal standard was not used because the blood sample 
has been already analyzed without the addition of an internal standard. LOD of 2 ng/mL was 
achieved and it was approximately femoral blood fentanyl level. 
Discussion 
Life threatening events and fatalities due to the transdermal fentanyl device can occur either 
due to the abuse (intentional inappropriate use), the misguided use (improper use for 
therapeutic purposes) or accidental use (unintentional contact of the non-user with the 
fentanyl patch).  
Only one case of the abuse of the fentanyl patch among children has been reported – a 15-
year-old girl attempted to commit a suicide by applying five fentanyl patches to the skin [8]. 
Much more often, life threatening events and deaths due the fentanyl patch among children 
pertain to the misguided use or to the accidental use. A great variety of the scenarios from 
these two categories have been reported [5-7, 9-11] which all share one characteristic – a lack 
of knowledge, information and attention among the adult users of the fentanyl patch. These 
include the accidental transfer of the patch from another person while hugging the child [5], 
placement of the patch on the child skin in order to relieve pain [6, 9], improper disposal of 
the used fentanyl patch which resulted in ingestion of the patch by the child in one case [10] 
and with self-application of the discarded patch to the skin by the child in another [7]. The 
inadvertent users of the fentanyl patches in these incidents were most often grandparents [5-7, 
9]. The contact of the fentanyl patch and the child was either completely accidental [5, 7, 10] 
or the patch was applied to the child skin in order to relieve acute pain [6, 9].  
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In this presented case, the patch was placed on the child skin with intent, but not to relieve the 
pain. The fentanyl patch was used in order to stop bleeding, and it seems that the grandmother 
was not even aware of the purpose of the fentanyl patch.      
The impact of applying fentanyl patch to the skin of opioid-naive child was amplified by the 
application of the patch over the bleeding abrasion. That increased the rate of absorption of 
fentanyl through the skin. The proper use of the fentanyl transdermal patch has been specified 
by the manufacturer, and FDA has so far issued three additional safety warnings pertaining to 
the need for proper use in order to avoid adverse events while using the patch [11-13]. The 
warning issued in 2007 stated the need to apply the patch over the skin that is intact [13]. Roy 
and Flynn have established that stratum corneum is the principle barrier for skin permeation 
and that permeability of the taped stripped skin without stratum corneum for fentanyl was 30 
times higher [14]. Furthermore, Gupta et. al. have reported that the application of the 
transdermal fentanyl patch to the broken skin can increase blood fentanyl concentrations by 5 
times [15]. A similar case [6] included a 6-year-old, 27-kg girl admitted to the hospital in the 
morning due to the altered mental status after her grandfather applied the Durogesic 25 μg/h 
transdermal patch over abrasion on her back the evening before. Fortunately, after the 
administration of naloxone, the patient was alert and talkative, and without the recurrence of 
the symptoms. 
Respiratory depression usually develops at serum fentanyl concentrations of 2 ng/mL or more, 
but the severity depends upon the patients’ age, pharmacokinetic response, ingestion of other 
sedative drugs, and depressed pulmonary function [16]. The concentration of the fentanyl in 
the femoral blood in our case was just above the level of detection (approximately 2 ng/mL). 
A recent study of Andresen et. al. concluded that the general guideline for interpretation of 
blood fentanyl concentration in a postmortem specimen concerning possible intoxication 
cannot be given due to wide concentration overlap in cases with fentanyl considered to be 
therapeutic and where is considered toxic [17]. This pertains even more to the cases involving 
small children, simply due to considerably small number of the observed cases.  
Reported pharmacokinetics of fentanyl shows broad interpatient and intrapatient variability 
[18]. In general, after single intravenous dose fentanyl tends to rapidly disappear from the 
blood [19]. This is due to the strong first-pass effect in the liver, with the majority of dose 
eliminated by the kidneys [19].  Furthermore, fentanyl exhibits wide tissue distribution with 
high extravascular volume of distribution [20]. In children, higher total body water leads to 
larger volume of distribution. In addition, clearance of fentanyl is greater than in adults 
leading to reduced elimination half-life [21]. Performed analysis in this case showed the 
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highest concentration of fentanyl in urine, followed by liver and kidney, while blood 
concentration was significantly lower (Table 1). Such pattern is consistent with other 
published data [10, 22, 23] and in accordance with expected behavior of the substance. 
Properly used transdermal fentanyl patch achieves controlled release of the substance over 
time. Specificity of the presented case includes application of the patch to damaged skin, thus 
allowing absorption rate which was substantially more rapid compared to the application on 
sound skin, in turn leading to earlier onset of elimination of the substance. Furthermore, the 
time interval from patch application to death of the child (between 7 and 12 hours) allowed 
clearance of the substance from blood and its accumulating in urine, thus producing the result 
observed by the toxicology analysis. 
After the evaluation of the medical history of the child, the police investigation of the case, 
autopsy findings and toxicology results, we have concluded that fentanyl intoxication was the 
cause of death of the child. The number of children fatally intoxicated with fentanyl is, 
fortunately, small.  
Low incidence of such events makes the body of knowledge on fentanyl pharmacokinetics in 
children incomplete. Therefore, we find this case to be a useful contribution to the evaluation 
of the level of postmortem concentrations of fentanyl in small child after the application of 
one Durogesic 25 μg/h patch where the fentanyl intoxication is considered the cause of death. 
Furthermore, we aim to emphasize the role of all participants in health-care systems in 
prevention of similar cases. The doctors prescribing transdermal fentanyl patch must provide 
the patients with thorough education on indications, risks and proper use, storage and disposal 
of this medicine since this is of crucial relevance in prevention of similar fatalities. 
Additionally, positive assessment of patient’s mental capability to follow the instructions 
given should be an obligatory task for each attending physician prior to prescribing such 
medications. Besides the additional effort of physicians, we find that pharmaceutical 
companies should find the solution to additionally accent the potency and hazard of 
transdermal fentanyl patch through more explicit and prominent labeling on the covers as well 
as on each individual package of this medication.  
Although fatal poisoning is uncommon among young children in well developed countries, it 
is of major interest to raise awareness of such events especially since great majority of these 
are preventable. This presented case illustrates the need for more thorough education of users 
and more strict rules in prescribing and handling of this potent medicine. 
At the same time, the case serves as a reminder for all medicolegal experts, especially those 
who are burdened with a high case load, to remain alert to notice minute findings at autopsy, 
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since these can occasionally be the clue for case-solving. Herein, the band-aid placed over the 
simple skin abrasion turned out to be an explanation for sudden and unexpected death of a 
child. 
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